Dr. Hedlund is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Campus Drive
Suite 108
Scarborough, ME 04074Phone+1 207-396-7600Fax+1 207-396-7986
Education & Training
University of Washington School of MedicineFellowship, Blood Banking/Transfusion Medicine, 1995 - 1996- University of WashingtonFellowship, Hematology and Medical Oncology, 1994 - 1995
Maine Medical CenterResidency, Internal Medicine, 1990 - 1994
University of Vermont College of MedicineClass of 1990
Certifications & Licensure
FL State Medical License 2020 - 2026
MA State Medical License 2015 - 2025
ME State Medical License 1993 - 2025
MS State Medical License 2017 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
- Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant Start of enrollment: 2013 May 16
Publications & Presentations
PubMed
- 30 citationsA Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple MyelomaJacob P. Laubach, Chia Jen Liu, Noopur Raje, Andrew Yee, Philippe Armand
Clinical Cancer Research. 2019-01-15 - 12 citationsHerpes simplex encephalitis as a complication of whole-brain radiotherapy: a case report and review of the literature.David J Sermer, Jamie L Woodley, Christian A Thomas, Jacquelyn A Hedlund
Case Reports in Oncology. 2014-11-21 - 30 citationsAttenuating homologous recombination stimulates an AID-induced antileukemic effect.Kristin Lamont, Muneer G. Hasham, Nina M Donghia, Jane Branca, Margaret Chavaree
The Journal of Experimental Medicine. 2013-05-06
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
